Viacor
Founded Year
1999Stage
Debt | DeadTotal Raised
$14.78MLast Raised
$6.58MLatest Viacor News
Jun 26, 2020
Outlook Into The Industrial Floorings Global Market To 2027 - Featuring Sika, Twintec & Viacor Polymer Among Others DUBLIN, June 26, 2020 /PRNewswire/ -- The "Industrial Floorings - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets. Author: Jun 26, 2020 3:45 PM EDT DUBLIN, June 26, 2020 /PRNewswire/ -- The "Industrial Floorings - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis and the looming economic recession, the Industrial Floorings market worldwide will grow by a projected US$1.7 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 2.8%. Automotive, one of the segments analyzed and sized in this study, is forecast to grow at over 2.1% and reach a market size of US$1.9 Billion by the end of the analysis period. The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Automotive market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions. As part of the new emerging geographic scenario, the United States is forecast to readjust to a 1.8% CAGR. Within Europe, Germany will add over US$38.6 Million to the region's size over the next 7 to 8 years. In addition, over US$44.7 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Automotive segment will reach a market size of US$60 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Industrial Floorings market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 5.5% over the next couple of years and add approximately US$542.4 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Industrial Floorings market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies. Competitors identified in this market include, among others, 4m Europe SA Global Competitor Market Shares
Viacor Frequently Asked Questions (FAQ)
When was Viacor founded?
Viacor was founded in 1999.
Where is Viacor's headquarters?
Viacor's headquarters is located at 260-B Fordham Road, Wilmington.
What is Viacor's latest funding round?
Viacor's latest funding round is Debt.
How much did Viacor raise?
Viacor raised a total of $14.78M.
Who are the investors of Viacor?
Investors of Viacor include Canaan Partners and New Enterprise Associates.
Who are Viacor's competitors?
Competitors of Viacor include NeoChord, Ancora Heart, Respicardia, TherOx, Mitralign and 13 more.
Compare Viacor to Competitors
Cardiac Power is a non-blood-contacting left ventricular assist device for the treatment of congestive heart failure
Bio Control Medical offers implantable devices for the treatment of incontinence and congestive heart failure.
CardioMetrix is a medical device company developing implantable technologies to assist physicians in managing patients suffering from congestive heart failure (CHF).
CardioKinetix develops a percutaneous treatment for patients with left ventricular dilation after an anterior myocardial infarction (MI). The implantable device, called the PARACHUTE is a partitioning membrane deployed within the compromised ventricle. The PARACHUTE partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, and decreases the overall volume. Options for patients whose ventricle has enlarged are limited, with most on medical therapy and/or a cardiac resynchronization device that only benefits heart failure patients with a specific EKG pattern.

Cardiac Dimensions develops minimally invasive treatment modalities to address heart failure and related cardiovascular conditions. Its initial technology platform, the CARILLON Mitral Contour System has been designed to address functional mitral regurgitation, utilizing a novel percutaneous approach. The company was founded in 2000 and is based in Kirkland, Washington.

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation, and is proven to resolve and restore normal mitral valve function. It was formerly known as mValve. The company was founded in 2007 and is based in St. Louis Park, Minnesota.